MEF2 transcription factors

Preferred Label : MEF2 transcription factors;

MeSH definition : Activating transcription factors of the MADS family which bind a specific sequence element (MEF2 element) in many muscle-specific genes and are involved in skeletal and cardiac myogenesis, neuronal differentiation and survival/apoptosis.;

MeSH synonym : transcription factors, MEF2; muscle enhancer Factor-2; enhancer Factor-2, muscle; muscle enhancer factor 2; Myocyte-Specific Enhancer-Binding factor 2; myocyte specific enhancer binding factor 2; myocyte enhancer factor 2; Myocyte-Specific enhancer factor 2; myocyte specific enhancer factor 2; MEF2 proteins; Muscle-Specific enhancer Factor-2; enhancer Factor-2, Muscle-Specific; muscle specific enhancer factor 2;

MeSH hyponym : MEF2C transcription factor; MEF2B transcription factor; MEF2D transcription factor; MEF2A transcription factor; Transcription Factor, MEF2B; Serum Response Factor-Like Protein 2; Serum Response Factor Like Protein 2; Myocyte-Specific Enhancer Factor 2B; Myocyte Specific Enhancer Factor 2B; Muscle Enhancer Factor-2B; Enhancer Factor-2B, Muscle; Muscle Enhancer Factor 2B; Muscle-Specific Enhancer Factor-2B; Enhancer Factor-2B, Muscle-Specific; Muscle Specific Enhancer Factor 2B; Myocyte Enhancer Factor 2B; Myocyte-Specific Enhancer-Binding Factor 2B; Myocyte Specific Enhancer Binding Factor 2B; MEF2B Protein; Transcription Factor, MEF2D; Muscle Enhancer Factor-2D; Enhancer Factor-2D, Muscle; Muscle Enhancer Factor 2D; Muscle-Specific Enhancer Factor-2D; Enhancer Factor-2D, Muscle-Specific; Muscle Specific Enhancer Factor 2D; Myocyte-Specific Enhancer Factor 2D; Myocyte Specific Enhancer Factor 2D; Myocyte-Specific Enhancer-Binding Factor 2D; Myocyte Specific Enhancer Binding Factor 2D; MEF2D Protein; Myocyte Enhancer Factor 2D; Transcription Factor, MEF2A; Muscle Enhancer Factor-2A; Enhancer Factor-2A, Muscle; Muscle Enhancer Factor 2A; Serum Response Factor-Like Protein 1; Serum Response Factor Like Protein 1; Myocyte Enhancer Factor 2A; Myocyte-Specific Enhancer Factor 2A; Myocyte Specific Enhancer Factor 2A; Myocyte-Specific Enhancer-Binding Factor 2A; Myocyte Specific Enhancer Binding Factor 2A; MEF2A Protein; Muscle-Specific Enhancer Factor-2A; Enhancer Factor-2A, Muscle-Specific; Muscle Specific Enhancer Factor 2A; Transcription Factor, MEF2C; Muscle Enhancer Factor-2C; Enhancer Factor-2C, Muscle; Muscle Enhancer Factor 2C; Myocyte-Specific Enhancer-Binding Factor 2C; Myocyte Specific Enhancer Binding Factor 2C; Myocyte Enhancer Factor 2C; Myocyte-Specific Enhancer Factor 2C; Myocyte Specific Enhancer Factor 2C; MEF2C Protein; Muscle-Specific Enhancer Factor-2C; Enhancer Factor-2C, Muscle-Specific; Muscle Specific Enhancer Factor 2C;

Is substance : O;

Details

Origin ID

D064326;

UMLS CUI

C3658245;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- deficiency [MeSH Qualifier]
- drug effects [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- ultrastructure [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Myocyte-Specific Enhancer Factor 2A [NCIt concept]
- Myocyte-Specific Enhancer Factor 2B [NCIt concept]
- Myocyte-Specific Enhancer Factor 2C [NCIt concept]
- Myocyte-Specific Enhancer Factor 2D [NCIt concept]
- myocyte enhancer factor 2A [HGNC gene]
- myocyte enhancer factor 2B [HGNC gene]
- myocyte enhancer factor 2C [ORDO Gene]
- myocyte enhancer factor 2C [HGNC gene]
- myocyte enhancer factor 2D [HGNC gene]
Record concept(s)
- MEF2 transcription factors [MeSH concept]
- MEF2A transcription factor [MeSH concept]
- MEF2B transcription factor [MeSH concept]
- MEF2C transcription factor [MeSH concept]
- MEF2D transcription factor [MeSH concept]
Related MeSH Supplementary Concept(s)
- FLH protein, Arabidopsis [MeSH Supplementary Concept]
- MEF2 protein, xenopus [MeSH Supplementary Concept]
- MEF2A protein, human [MeSH Supplementary Concept]
- MEF2A protein, rat [MeSH Supplementary Concept]
- MEF2B protein, human [MeSH Supplementary Concept]
- MEF2C protein, human [MeSH Supplementary Concept]
- MEF2C protein, rat [MeSH Supplementary Concept]
- MEF2D protein, human [MeSH Supplementary Concept]
- MEF2D protein, rat [MeSH Supplementary Concept]
- Mef2a protein, mouse [MeSH Supplementary Concept]
- Mef2b protein, mouse [MeSH Supplementary Concept]
- Mef2c protein, mouse [MeSH Supplementary Concept]
- Mef2ca protein, zebrafish [MeSH Supplementary Concept]
- Mef2d protein, mouse [MeSH Supplementary Concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Biologically Active Substance [UMLS semantic type]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients